Coric Vlad

Director Coric Vlad bought 117,646 shares ($2.0M) at $17.00 in 2 transactions; concurrent cluster buy by 4 insiders in IPO window.

Director Coric Vlad executed 2 purchases totaling 117,646 shares for $1,999,982.00 at $17.00 on 2026-02-05, increasing his holdings to 319,398 shares from 201,752 shares—a net increase of 58.3% in his position. The timing coincides with Veradermics' recent listing (2 trading days old as of the transaction date), and the current price of $37.16 reflects a 118% premium to the purchase price, suggesting strong post-IPO momentum. Notably, 4 other insiders also bought within the past 14 days, forming a cluster buy pattern during the early trading window. This concentrated insider purchasing activity during the post-IPO period, combined with the significant position expansion and the parallel activity by multiple directors, signals alignment between management and the offering valuation at a critical early moment for the company's public trading history.

CEO Coric Vlad purchased 666,666 shares at $7.50 for $4,999,995.00; holdings surge 902.4%; cluster buy pattern with 3 other insiders in 14 days

Coric Vlad, CEO of Biohaven Ltd., executed two separate purchases totaling 666,666 shares at $7.50 on 2025-11-13, expanding his holdings from 73,880 shares to 740,546 shares—a 902.4% increase. The transaction occurred against a backdrop of significant price weakness: the stock is down 83.6% from its 52-week high of $50.36 and down 48.2% over the past 30 days, placing this purchase near recent lows. This activity is reinforced by a cluster pattern: 3 other insiders also bought within the past 14 days, suggesting coordinated confidence or response to company developments rather than an isolated insider action. However, Biohaven is operating at a substantial loss, with full-year net income of $-173,443,000.00, and the CEO's same-ticker purchase history at Biohaven shows mixed outcomes—2 of 4 prior buys at this ticker yielded positive 90-day returns, while 2 saw 30-day declines. The confluence of a cluster buy by leadership during a sharp drawdown in an unprofitable company warrants close attention to underlying catalysts.

Coric Vlad (CEO) purchases 21,052 BHVN shares at $47.50; cluster buy pattern with 2 other insiders in 14 days

CEO Coric Vlad purchased 21,052 shares at $47.50 on 2024-10-02, increasing his stake by 2.5% to 861,942 shares. The purchase occurred as the stock was at -21.9% from its 52-week high but up +22.2% over the prior 30 days, and coincided with 2 other insiders buying within the past 14 days—a cluster pattern that may signal synchronized confidence in near-term prospects. However, Vlad's same-ticker history at BHVN shows mixed timing: his April 2024 buy declined -7.3% over 30 days, while his October 2023 purchases gained +40.1% at 30 days; only 2 of his 3 prior BHVN trades were well-timed at the 90-day mark. The company remains unprofitable with net income of $-319,771,000.00 over its most recent full fiscal year, a fundamental headwind that offsets any positive reading from the insider cluster and recent price momentum.